{"pmid":32390931,"pmcid":"PMC7188982","title":"A Case of Coronavirus Disease 2019 With Concomitant Acute Cerebral Infarction and Deep Vein Thrombosis.","text":["A Case of Coronavirus Disease 2019 With Concomitant Acute Cerebral Infarction and Deep Vein Thrombosis.","We report a case of a 75-year-old woman diagnosed with severe coronavirus disease 2019 (COVID-19) complicated by acute cerebral infarction. The patient was admitted to our hospital on 5 February 2020 with severe COVID-19. On 20 February 2020, she was diagnosed with concomitant acute cerebral infarction via head computed tomography (CT) and deep vein thrombosis in both lower limbs. After symptomatic and supportive treatments, the patient was discharged on 13 March 2020. She will comply with quarantine for another 2 weeks and receive rehabilitation training from a specialist doctor. Cerebral infarction should be considered and promptly managed in patients with COVID-19.","Front Neurol","Zhou, Bo","She, Jianqing","Wang, Yadan","Ma, Xiancang","32390931"],"abstract":["We report a case of a 75-year-old woman diagnosed with severe coronavirus disease 2019 (COVID-19) complicated by acute cerebral infarction. The patient was admitted to our hospital on 5 February 2020 with severe COVID-19. On 20 February 2020, she was diagnosed with concomitant acute cerebral infarction via head computed tomography (CT) and deep vein thrombosis in both lower limbs. After symptomatic and supportive treatments, the patient was discharged on 13 March 2020. She will comply with quarantine for another 2 weeks and receive rehabilitation training from a specialist doctor. Cerebral infarction should be considered and promptly managed in patients with COVID-19."],"journal":"Front Neurol","authors":["Zhou, Bo","She, Jianqing","Wang, Yadan","Ma, Xiancang"],"date":"2020-05-12T11:00:00Z","year":2020,"_id":"32390931","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.3389/fneur.2020.00296","keywords":["covid-19","ct","acute cerebral infarction","case","thrombosis"],"topics":["Case Report"],"weight":1,"_version_":1666528580061888512,"score":9.490897,"similar":[{"pmid":32376583,"pmcid":"PMC7167313","title":"[Diagnosis and treatment of an elderly patient with secondary cerebral infarction caused by COVID-19].","text":["[Diagnosis and treatment of an elderly patient with secondary cerebral infarction caused by COVID-19].","We review the experience with the diagnosis and treatment of secondary cerebral infarction in an elderly patient with coronavirus disease 2019 (COVID-19). COVID-19 has rapid disease progression with a high mortality rate in elderly patients, and physicians should be alert to secondary bacterial infection that may result in coagulation dysfunction and cerebral infarction. Early anti-infection therapy, immune regulation and appropriate anticoagulation intervention may help improve the prognosis of the patients.","Nan Fang Yi Ke Da Xue Xue Bao","He, Jin","Cheng, Gong","Xu, Wenwei","Zhang, Lengzhen","Zeng, Zhenhua","32376583"],"abstract":["We review the experience with the diagnosis and treatment of secondary cerebral infarction in an elderly patient with coronavirus disease 2019 (COVID-19). COVID-19 has rapid disease progression with a high mortality rate in elderly patients, and physicians should be alert to secondary bacterial infection that may result in coagulation dysfunction and cerebral infarction. Early anti-infection therapy, immune regulation and appropriate anticoagulation intervention may help improve the prognosis of the patients."],"journal":"Nan Fang Yi Ke Da Xue Xue Bao","authors":["He, Jin","Cheng, Gong","Xu, Wenwei","Zhang, Lengzhen","Zeng, Zhenhua"],"date":"2020-05-08T11:00:00Z","year":2020,"_id":"32376583","source":"PubMed","week":"202019|May 04 - May 10","doi":"10.12122/j.issn.1673-4254.2020.03.10","keywords":["covid-19","cerebral infarction","elderly patients","secondary bacterial infection"],"topics":["Treatment","Diagnosis"],"weight":1,"_version_":1666597097394143232,"score":242.19086},{"pmid":32399457,"pmcid":"PMC7213833","title":"Cerebral Venous Sinus Thrombosis as a Presentation of COVID-19.","text":["Cerebral Venous Sinus Thrombosis as a Presentation of COVID-19.","Coronavirus disease 19 (COVID-19) is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). We describe the case of a 59-year-old man who presented with headache, hypertension and a single episode of fever with no other symptoms. He subsequently developed unilateral weakness. Computer tomography identified a cerebral venous sinus thrombosis (CVST). A subsequent test for COVID-19 was positive. This is the first report of CVST as a presenting symptom of COVID-19 infection. LEARNING POINTS: Thrombotic events may be the initial presenting symptom of COVID-19.These thrombotic events include stroke, venous thromboembolism, pulmonary embolism and cardiac complications.Clinicians should carefully consider the risk of thrombosis in patients positive for COVID-19, including prophylaxis and treatment beyond discharge.","Eur J Case Rep Intern Med","Hughes, Christopher","Nichols, Tom","Pike, Martin","Subbe, Christian","Elghenzai, Salah","32399457"],"abstract":["Coronavirus disease 19 (COVID-19) is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). We describe the case of a 59-year-old man who presented with headache, hypertension and a single episode of fever with no other symptoms. He subsequently developed unilateral weakness. Computer tomography identified a cerebral venous sinus thrombosis (CVST). A subsequent test for COVID-19 was positive. This is the first report of CVST as a presenting symptom of COVID-19 infection. LEARNING POINTS: Thrombotic events may be the initial presenting symptom of COVID-19.These thrombotic events include stroke, venous thromboembolism, pulmonary embolism and cardiac complications.Clinicians should carefully consider the risk of thrombosis in patients positive for COVID-19, including prophylaxis and treatment beyond discharge."],"journal":"Eur J Case Rep Intern Med","authors":["Hughes, Christopher","Nichols, Tom","Pike, Martin","Subbe, Christian","Elghenzai, Salah"],"date":"2020-05-14T11:00:00Z","year":2020,"_id":"32399457","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.12890/2020_001691","keywords":["covid-19","anticoagulation","cerebral venous sinus thrombosis","stroke"],"topics":["Case Report"],"weight":1,"_version_":1666865855101665280,"score":215.28563},{"pmid":32409316,"title":"Cerebrovascular Disease in COVID-19.","text":["Cerebrovascular Disease in COVID-19.","Coronavirus disease 19 (COVID-19) is a pandemic originating in Wuhan, China, in December 2019. Early reports suggest that there are neurologic manifestations of COVID-19, including acute cerebrovascular disease. We report a case of COVID-19 with acute ischemic stroke. To our knowledge, this is the first reported case of COVID-19-related cerebral infarcts that includes brain imaging at multiple time points and CT angiography. There is a growing body of published evidence that complications of COVID-19 are not limited to the pulmonary system. Neuroradiologists should be aware of a wide range of neurologic manifestations, including cerebrovascular disease.","AJNR Am J Neuroradiol","Goldberg, Michael F","Goldberg, Morton F","Cerejo, R","Tayal, A H","32409316"],"abstract":["Coronavirus disease 19 (COVID-19) is a pandemic originating in Wuhan, China, in December 2019. Early reports suggest that there are neurologic manifestations of COVID-19, including acute cerebrovascular disease. We report a case of COVID-19 with acute ischemic stroke. To our knowledge, this is the first reported case of COVID-19-related cerebral infarcts that includes brain imaging at multiple time points and CT angiography. There is a growing body of published evidence that complications of COVID-19 are not limited to the pulmonary system. Neuroradiologists should be aware of a wide range of neurologic manifestations, including cerebrovascular disease."],"journal":"AJNR Am J Neuroradiol","authors":["Goldberg, Michael F","Goldberg, Morton F","Cerejo, R","Tayal, A H"],"date":"2020-05-16T11:00:00Z","year":2020,"_id":"32409316","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.3174/ajnr.A6588","locations":["Wuhan","China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Case Report"],"weight":1,"_version_":1666897319150223360,"score":185.17046},{"pmid":32335249,"pmcid":"PMC7177144","title":"Severe Acute Respiratory Syndrome Coronavirus 2 Infection and the Upper Limb Deep Vein Thrombosis Risk.","text":["Severe Acute Respiratory Syndrome Coronavirus 2 Infection and the Upper Limb Deep Vein Thrombosis Risk.","Little or nothing is known about the correlation between the upper limb deep vein thrombosis (UL-DVT) and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). We describe the increased risk of UL-DVT in 3 patients with SARS-CoV-2 who require continuous positive airway pressure with a hood and the need for early adequate antithrombotic prophylaxis.","Ann Vasc Surg","Bozzani, Antonio","Arici, Vittorio","Franciscone, Mila Maria","Danesino, Vittorio","Cascina, Alessandro","Ticozzelli, Giulia","Ragni, Franco","32335249"],"abstract":["Little or nothing is known about the correlation between the upper limb deep vein thrombosis (UL-DVT) and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). We describe the increased risk of UL-DVT in 3 patients with SARS-CoV-2 who require continuous positive airway pressure with a hood and the need for early adequate antithrombotic prophylaxis."],"journal":"Ann Vasc Surg","authors":["Bozzani, Antonio","Arici, Vittorio","Franciscone, Mila Maria","Danesino, Vittorio","Cascina, Alessandro","Ticozzelli, Giulia","Ragni, Franco"],"date":"2020-04-27T11:00:00Z","year":2020,"_id":"32335249","source":"PubMed","week":"202018|Apr 27 - May 03","doi":"10.1016/j.avsg.2020.04.037","topics":["Case Report"],"weight":1,"_version_":1666138494136745984,"score":183.09438},{"pmid":32307298,"pmcid":"PMC7162634","title":"Severe cerebral involvement in adult-onset hemophagocytic lymphohistiocytosis.","text":["Severe cerebral involvement in adult-onset hemophagocytic lymphohistiocytosis.","The diagnosis of hemophagocytic lymphohistiocytosis (HLH) with cerebral involvement is challenging given the rarity of HLH and its resemblance to the much more common severe sepsis. Timely diagnosis and treatment may be lifesaving. We report two cases demonstrating different and rare forms of severe brain involvement in adult patients with HLH: acute necrotizing encephalopathy, and diffuse hemorrhagic disease due to disseminated intravascular coagulation. Severe HLH with brain involvement in adults is rare. HLH with cerebral involvement should be considered in patients presenting with severe systemic inflammatory response syndrome (SIRS) but negative cultures and unusual or unexpectedly severe clinical and/or radiologic signs of cerebral dysfunction. Similar brain injury may occur in patients with cytokine storm syndrome due to COVID-19. BACKGROUND: Hemophagocytic lymphohistiocytosis (HLH) presents with fevers, rash, organomegaly, cytopenia, and increased triglycerides and ferritin (Ramos-Casals et al., 2014) [1]. Neurologic abnormalities are reported in about one-third of patients (Cai et al., 2017), including a few cases of acute necrotizing encephalopathy (ANE) (Xiujuan et al., 2015). Coagulation abnormalities are frequent in HLH patients (Valade et al., 2015). OBJECTIVE: To raise awareness about the importance of early diagnosis and treatment of HLH with neurological involvement to prevent serious complications and demise.","J Clin Neurosci","Radmanesh, Farid","Rodriguez-Pla, Alicia","Pincus, Michael D","Burns, Joseph D","32307298"],"abstract":["The diagnosis of hemophagocytic lymphohistiocytosis (HLH) with cerebral involvement is challenging given the rarity of HLH and its resemblance to the much more common severe sepsis. Timely diagnosis and treatment may be lifesaving. We report two cases demonstrating different and rare forms of severe brain involvement in adult patients with HLH: acute necrotizing encephalopathy, and diffuse hemorrhagic disease due to disseminated intravascular coagulation. Severe HLH with brain involvement in adults is rare. HLH with cerebral involvement should be considered in patients presenting with severe systemic inflammatory response syndrome (SIRS) but negative cultures and unusual or unexpectedly severe clinical and/or radiologic signs of cerebral dysfunction. Similar brain injury may occur in patients with cytokine storm syndrome due to COVID-19. BACKGROUND: Hemophagocytic lymphohistiocytosis (HLH) presents with fevers, rash, organomegaly, cytopenia, and increased triglycerides and ferritin (Ramos-Casals et al., 2014) [1]. Neurologic abnormalities are reported in about one-third of patients (Cai et al., 2017), including a few cases of acute necrotizing encephalopathy (ANE) (Xiujuan et al., 2015). Coagulation abnormalities are frequent in HLH patients (Valade et al., 2015). OBJECTIVE: To raise awareness about the importance of early diagnosis and treatment of HLH with neurological involvement to prevent serious complications and demise."],"journal":"J Clin Neurosci","authors":["Radmanesh, Farid","Rodriguez-Pla, Alicia","Pincus, Michael D","Burns, Joseph D"],"date":"2020-04-21T11:00:00Z","year":2020,"_id":"32307298","source":"PubMed","week":"202017|Apr 20 - Apr 26","doi":"10.1016/j.jocn.2020.04.054","keywords":["acute necrotizing encephalopathy","adult onset still's disease","diffuse hemorrhagic encephalopathy","disseminated intravascular coagulation","hemophagocytic syndrome"],"locations":["organomegaly","cytopenia"],"e_drugs":["Triglycerides"],"topics":["Case Report"],"weight":1,"_version_":1666138491286716416,"score":182.0702}]}